首页> 美国卫生研究院文献>British Journal of Cancer >Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.

【2h】

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.

机译：卡铂联合口服依托泊苷治疗老年小细胞肺癌的二期试验。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

获取外文期刊封面目录资料

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

A phase II trial was conducted to evaluate the efficacy and toxicity of the Egorin's carboplatin dosing formula with 14-day oral etoposide in 38 elderly patients with small-cell lung cancer (SCLC). The overall response rate was 81%. Median survival times were 15.1 months for 16 limited-disease (LD) and 8.6 months for 22 extensive-disease (ED) patients. Myelosuppression was the principal side-effect. This regimen is an active regimen in the treatment of elderly SCLC patients.

机译：进行了一项II期临床试验，以评估Egorin的卡铂给药配方与14天口服依托泊苷对38例老年小细胞肺癌（SCLC）的疗效和毒性。总体回应率为81％。中位生存时间为16例有限疾病（LD）的15.1个月和22例严重疾病（ED）的8.6个月。骨髓抑制是主要的副作用。该方案是治疗老年SCLC患者的有效方案。

著录项

期刊名称 British Journal of Cancer
作者
K. Matsui; N. Masuda; M. Fukuoka; T. Yana; T. Hirashima; T. Komiya; M. Kobayashi; M. Kawahara; S. Atagi; M. Ogawara; S. Negoro; S. Kudoh; K. Furuse;
展开▼
作者单位

展开▼
年(卷),期 1998(77),11
年度 1998
页码 1961–1965
总页数 5
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Randomized phase III trial of paclitaxel, etoposide, and carboplatin versus carboplatin, etoposide, and vincristine in patients with small-cell lung cancer. [J] . Reck M, von-Pawel J, Macha HN, Journal of the National Cancer Institute . 2003,第15期

机译：紫杉醇，依托泊苷和卡铂与卡铂，依托泊苷和长春新碱在小细胞肺癌患者中的随机III期试验。
2. Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer [J] . K Matsui, N Masuda, M Fukuoka, British Journal of Cancer . 1998,第11期

机译：卡铂联合口服依托泊苷治疗老年小细胞肺癌的二期试验
3. Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer [J] . K Matsui, N Masuda, M Fukuoka, British Journal of Cancer . 1998,第11期

机译：卡铂联合口服依托泊苷治疗老年小细胞肺癌的二期试验
4. PHASE III COMPARISON OF CARBOPLATIN VERSUS CARBOPLATIN AND DOXORUBICIN FOR THE ADJUVANT TREATMENT OF APPENDICULAR OSTEOSARCOMA: INTERIM ANALYSIS [C] . Katherine Skorupski, Justin Uhl, Stephen Shaw, Annual Conference of the Veterinary Cancer Society . 2009

机译：Carboplatin与Carboplatin和多柔比星的相位III比较，用于辅助骨肉瘤的佐剂治疗：临时分析
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. Randomised phase III trial of carboplatin plus etoposide vs split doses of cisplatin plus etoposide in elderly or poor-risk patients with extensive disease small-cell lung cancer: JCOG 9702 [O] . H Okamoto, K Watanabe, H Kunikane, 2007

机译：卡铂+依托泊苷与分剂量的顺铂+依托泊苷对老年或低危广泛性疾病小细胞肺癌患者的随机III期试验：JCOG 9702
7. Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer. [O] . Matsui, K., Masuda, N., Fukuoka, M., 1998

机译：卡铂联合口服依托泊苷治疗老年小细胞肺癌的二期试验。

Phase II trial of carboplatin plus oral etoposide for elderly patients with small-cell lung cancer.

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅